Mavroidis P, Costa Ferreira B, Shi C, Lind B K, Papanikolaou N
Department of Medical Radiation Physics, Karolinska Institutet and Stockholm University, Stockholm, Sweden.
J BUON. 2008 Jan-Mar;13(1):75-86.
Intensity modulated radiotherapy (IMRT) using multileaf collimators (MLC) and helical tomotherapy (HT) have become increasingly popular over the past few years. However, their clinical efficacy and effectiveness continue to be investigated. In order to provide a more thorough evaluation and comparison of treatment plans, the utilization of the biologically effective uniform dose (D) together with the complication-free tumor control probability (P(+)) are examined.
In this study, a typical case of lung cancer was investigated by developing a 3D conformal treatment plan, a linac MLC-based step-and-shoot IMRT plan and a HT plan. The 3 different treatment plans were compared based on radiobiological measures by using the P(+) index and the D concept as the common prescription point of the plans and plotting the tissue response probabilities vs. D for a range of prescription doses.
The applied plan evaluation method showed that in this lung cancer case the MLC-based IMRT plan was best over the clinically useful dose prescription range. The 3D-conformal, MLC-based IMRT and HT treatment plans gave a P(+) of 55.4%, 72.9% and 66.9%, for a D to the internal target volume (ITV) of 57.0 Gy, 66.9 Gy and 64.0 Gy, respectively.
In comparison to 3D conformal radiotherapy, both MLC based-IMRT and HT can better encompass the often large ITV required while minimizing the volume of the organs at risk receiving high dose. Taking into account the dose-response relations of the irradiated tumors and normal tissues, a radiobiological treatment plan evaluation can be performed, which may provide a closer association of the delivered treatment with the clinical outcome.
在过去几年中,使用多叶准直器(MLC)的调强放射治疗(IMRT)和螺旋断层放射治疗(HT)越来越受欢迎。然而,它们的临床疗效仍在持续研究中。为了更全面地评估和比较治疗方案,研究了生物等效均匀剂量(D)与无并发症肿瘤控制概率(P(+))的应用。
在本研究中,通过制定三维适形治疗计划、基于直线加速器MLC的静态调强放射治疗计划和螺旋断层放射治疗计划,对一个典型肺癌病例进行了研究。以P(+)指数和D概念作为计划的共同处方点,通过放射生物学测量比较了3种不同的治疗方案,并针对一系列处方剂量绘制了组织反应概率与D的关系图。
应用的计划评估方法表明,在该肺癌病例中,基于MLC的调强放射治疗计划在临床有用的剂量处方范围内是最佳的。对于内部靶区(ITV)的D分别为57.0 Gy、66.9 Gy和64.0 Gy时,三维适形、基于MLC的调强放射治疗和螺旋断层放射治疗计划的P(+)分别为55.4%、72.9%和66.9%。
与三维适形放射治疗相比,基于MLC的调强放射治疗和螺旋断层放射治疗都能更好地涵盖通常所需的较大内部靶区,同时将高剂量照射下的危及器官体积降至最低。考虑到受照射肿瘤和正常组织的剂量反应关系,可以进行放射生物学治疗计划评估这可能会使所给予的治疗与临床结果更紧密相关。